col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


264 Results       Page 1

 [1] 
Elsevier: The Lancet Regional Health - Europe
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―08 Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023 Katherina Aguilera, Oscar Bladh, Ulrika Marking, Nina Greilert Norin, Ali Rihani, Dorina Ujvari, et al. (+7)
2 [GO] 2024―Feb―02 Efficacy of MP1032 in hospitalised patients with COVID-19 Jing Liu, Xiangting Liu, Shulan Liu, Guangting Zeng
3 [GO] 2024―Feb―02 Efficacy of MP1032 in hospitalised patients with COVID-19- authors’ reply Petra Sager, Astrid Kaiser, Sara Schumann, Beate Ludescher, Wolfgang Brysch
4 [GO] 2024―Feb―02 In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project Pontus Hedberg, Milosz Parczewski, Karol Serwin, Giulia Marchetti, Francesca Bai, Björn-Erik Ole Jensen, et al. (+16)
5 [GO] 2023―Dec―14 Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort Peter D. Kirwan, Victoria J. Hall, Sarah Foulkes, Ashley D. Otter, Katie Munro, Dominic Sparkes, et al. (+257)
6 [GO] 2023―Dec―12 Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales Stuart Bedston, Fatima Almaghrabi, Lynsey Patterson, Utkarsh Agrawal, Lana Woolford, Sneha N. Anand, et al. (+16)
7 [GO] 2023―Dec―06 Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial Petra Sager, Astrid Kaiser, Sara Schumann, Beate Ludescher, Michael Niedermaier, Ivo Schmidt, et al. (+4)
8 [GO] 2023―Dec―01 Excess mortality in England post Covid-19 pandemic: implications for secondary prevention Jonathan Pearson-Stuttard, Sarah Caul, Stuart McDonald, Emily Whamond, John N. Newton
9 [GO] 2023―Nov―17 Incremental benefit of booster vaccinations for COVID-19 in the United Kingdom Benjamin J. Cowling, Sheena G. Sullivan
10 [GO] 2023―Nov―07 Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis Fabian Kerwagen, Uwe Riemer, Rolf Wachter, Stephan von Haehling, Amr Abdin, Michael Böhm, et al. (+2)
11 [GO] 2023―Oct―27 COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark Qing Shen, Emily E. Joyce, Omid V. Ebrahimi, Maria Didriksen, Anikó Lovik, Karen Sól Sævarsdóttir, et al. (+26)
12 [GO] 2023―Oct―26 Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England Freja Cordelia Møller Kirsebom, Katie Harman, Rachel Jayne Lunt, Nick Andrews, Natalie Groves, Nurin Abdul Aziz, et al. (+7)
13 [GO] 2023―Oct―13 Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study Rachael A. Evans, Sabada Dube, Yi Lu, Mark Yates, Sofie Arnetorp, Eleanor Barnes, et al. (+12)
14 [GO] 2023―Oct―11 Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt Daniele De Luca, Manuel Sanchez-Luna, Karl Schettler, Louis Bont, Eugenio Baraldi
15 [GO] 2023―Oct―09 Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform Bang Zheng, John Tazare, Linda Nab, Amelia CA. Green, Helen J. Curtis, Viyaasan Mahalingasivam, et al. (+18)
16 [GO] 2023―Sep―29 Physical fitness among children with diverse weight status during and after the COVID-19 pandemic: a population-wide, cohort study based on the Slovenian physical fitness surveillance system (SLOfit) Antonio Martinko, Maroje Sorić, Gregor Jurak, Gregor Starc
17 [GO] 2023―Sep―04 Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients - an observational study of five cohorts across four countries Anikó Lovik, Juan González-Hijón, Asle Hoffart, Chloe Fawns-Ritchie, Ingibjörg Magnúsdóttir, Li Lu, et al. (+21)
18 [GO] 2023―Aug―30 Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden Kim Blom, Oscar Bladh, Sebastian Havervall, Ulrika Marking, Nina Greilert Norin, Jessica J. Alm, et al. (+2)
19 [GO] 2023―Aug―08 Shifts in patterns of mental health burden during the COVID-19 pandemic Alex Dregan, David Armstrong
20 [GO] 2023―Jul―31 Reassurance on bleeding and thrombotic events following second dose BNT162b2 and ChAdOx1 COVID-19 vaccines Sue Pavord, Will Lester
21 [GO] 2023―Jul―21 Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in England Vicky P. Taxiarchi, Morwenna Senior, Darren M. Ashcroft, Matthew J. Carr, Holly Hope, Matthew Hotopf, et al. (+7)
22 [GO] 2023―Jul―18 Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data Andrea De Vito, Agnese Colpani, Giordano Madeddu
23 [GO] 2023―Jul―14 Real-life comparison of mortality in non-hospitalised patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrevir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, Carlo Tascini, Simone Celant, Danilo Tacconi, et al. (+18)
24 [GO] 2023―Jul―10 Were cancer patients worse off than the general population during the COVID-19 pandemic? A population-based study from Norway, Denmark and Iceland during the pre-vaccination era Anna L.V. Johansson, Anna Skog, Tom Børge Johannesen, Tor Åge Myklebust, Charlotte Wessel Skovlund, Lina Steinrud Mørch, et al. (+11)
25 [GO] 2023―Jul―01 Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis Wilhelmine Meeraus, Leonie de Munter, Christen M. Gray, Akshat Dwivedi, Chloé Wyndham-Thomas, Mario Ouwens, et al. (+14)
26 [GO] 2023―Jun―25 Post COVID-19 condition, work ability and occupational changes in a population-based cohort Philipp Kerksieck, Tala Ballouz, Sarah R. Haile, Celine Schumacher, Joanne Lacy, Anja Domenghino, et al. (+5)
27 [GO] 2023―Jun―16 Timing and sequence of vaccination against COVID-19 and influenza - Author's reply Elisabeth A. Dulfer, Büsra Geckin, Esther J.M. Taks, Corine H. GeurtsvanKessel, Helga Dijkstra, Liesbeth van Emst, et al. (+7)
28 [GO] 2023―May―30 Timing and sequence of vaccination against COVID-19 and influenza Jing Liu, Xiangting Liu, Shulan Liu, Guangting Zeng
29 [GO] 2023―May―26 From emergency response to long-term management: the many faces of the endemic state of COVID-19 Seba Contreras, Emil N. Iftekhar, Viola Priesemann
30 [GO] 2023―May―16 Impact of COVID-19 on broad-spectrum antibiotic prescribing for common infections in primary care in England: a time-series analyses using OpenSAFELY and effects of predictors including deprivation Xiaomin Zhong, Alexander Pate, Ya-Ting Yang, Ali Fahmi, Darren M. Ashcroft, Ben Goldacre, et al. (+9)
31 [GO] 2023―May―15 The impact of the Covid-19 pandemic on postnatal depression: analysis of three population-based national maternity surveys in England (2014-2020) Siân Harrison, Maria A. Quigley, Gracia Fellmeth, Alan Stein, Fiona Alderdice
32 [GO] 2023―May―10 Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines Rosemary J. Boyton, Daniel M. Altmann
33 [GO] 2023―May―06 Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study Linnea Vikström, Peter Fjällström, Yong-Dae Gwon, Daniel J. Sheward, Julia Wigren-Byström, Magnus Evander, et al. (+16)
34 [GO] 2023―May―03 Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study Edward P.K. Parker, Elsie M.F. Horne, William J. Hulme, John Tazare, Bang Zheng, Edward J. Carr, et al. (+12)
35 [GO] 2023―Apr―28 Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls Bang Zheng, Giulia Vivaldi, Luke Daines, Olivia C. Leavy, Matthew Richardson, Omer Elneima, et al. (+1036)
36 [GO] 2023―Apr―14 Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial Júlia Corominas, Carme Garriga, Antoni Prenafeta, Alexandra Moros, Manuel Cañete, Antonio Barreiro, et al. (+50)
37 [GO] 2023―Apr―12 Timing and sequence of vaccination against COVID-19 and influenza (TACTIC): a single-blind, placebo-controlled randomized clinical trial Elisabeth A. Dulfer, Büsra Geckin, Esther J.M. Taks, Corine H. GeurtsvanKessel, Helga Dijkstra, Liesbeth van Emst, et al. (+8)
38 [GO] 2023―Mar―31 Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants? Pengfei Jin, Fengcai Zhu
39 [GO] 2023―Mar―23 Attitudes towards booster, testing and isolation, and their impact on COVID-19 response in winter 2022/2023 in France, Belgium, and Italy: a cross-sectional survey and modelling study Giulia de Meijere, Eugenio Valdano, Claudio Castellano, Marion Debin, Charly Kengne-Kuetche, Clément Turbelin, et al. (+6)
40 [GO] 2023―Mar―18 SARS-CoV-2 variant-related abnormalities detected by prenatal MRI: direct or indirect effects of the infection must be demonstrated-Authors’ reply Patric Kienast, Daniela Prayer, Julia Binder, Florian Prayer, Sabine Dekan, Eva Langthaler, et al. (+4)
41 [GO] 2023―Mar―16 SARS-CoV-2 variant-related abnormalities detected by prenatal MRI: direct or indirect effects of the infection must be demonstrated Josef Finsterer
42 [GO] 2023―Mar―09 Polysubstance use and its correlation with psychosocial and health risk behaviours among more than 95,000 Norwegian adolescents during the COVID-19 pandemic (January to May 2021): a latent profile analysis Rubén Rodríguez-Cano, George Kypriotakis, Laura Cortés-García, Anders Bakken, Tilmann von Soest
43 [GO] 2023―Mar―07 Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study Charlotte Warren-Gash, Jennifer A. Davidson, Helen Strongman, Emily Herrett, Liam Smeeth, Judith Breuer, Amitava Banerjee
44 [GO] 2023―Feb―28 Learning from the COVID-19 pandemic response to strengthen undocumented migrant-sensitive health systems: case studies from four countries Eleonora Genovese, Kathleen R. Page, Johann Cailhol, Yves Jackson
45 [GO] 2023―Feb―27 Factors associated with receipt of COVID-19 vaccination and SARS-CoV-2 seropositivity among healthcare workers in Albania (February 2021-June 2022): secondary analysis of a prospective cohort study Pernille Jorgensen, Alexis Schmid, Jonilda Sulo, Iria Preza, Iris Hasibra, Esther Kissling, et al. (+11)
46 [GO] 2023―Jan―21 SARS-CoV-2 variant-related abnormalities detected by prenatal MRI: a prospective case-control study Patric Kienast, Daniela Prayer, Julia Binder, Florian Prayer, Sabine Dekan, Eva Langthaler, et al. (+9)
47 [GO] 2023―Jan―19 Coenzyme Q10 therapy in patients with post COVID-19 condition Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
48 [GO] 2023―Jan―19 Coenzyme Q10 therapy in patients with post COVID-19 condition - Authors’ response Kristoffer Skaalum Hansen, Steffen Leth
49 [GO] 2023―Jan―06 Mass testing to end the COVID-19 public health threat Cecile Philippe, Yaneer Bar-Yam, Stephane Bilodeau, Carlos Gershenson, Sunil K. Raina, Shu-Ti Chiou, et al. (+2)
50 [GO] 2023―Jan―05 Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry Guillaume Favre, Emeline Maisonneuve, Léo Pomar, Charlotte Daire, Christophe Poncelet, Thibaud Quibel, et al. (+75)
51 [GO] 2022―Dec―12 Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom Catherine Hyams, Robert Challen, Robin Marlow, Jennifer Nguyen, Elizabeth Begier, Jo Southern, et al. (+68)
52 [GO] 2022―Dec―07 Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study Anastasia Chatzilena, Catherine Hyams, Rob Challen, Robin Marlow, Jade King, David Adegbite, et al. (+58)
53 [GO] 2022―Dec―05 Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: A prospective follow-up study over 12 months Snehal M. Pinto Pereira, Roz Shafran, Manjula D. Nugawela, Laura Panagi, Dougal Hargreaves, Shamez N. Ladhani, et al. (+11)
54 [GO] 2022―Nov―11 Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England Freja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, Natalie Groves, Meera Chand, Mary Ramsay, Jamie Lopez Bernal
55 [GO] 2022―Nov―10 Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany Hermann Brenner, Rafael Cardoso, Thomas Heisser, Michael Hoffmeister, Bernd Holleczek
56 [GO] 2022―Nov―02 High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: A randomized, phase 2, crossover trial Kristoffer S. Hansen, Trine H. Mogensen, Jane Agergaard, Berit Schiøttz-Christensen, Lars Østergaard, Line K. Vibholm, Steffen Leth
57 [GO] 2022―Sep―28 BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12-17 years in Scotland Igor Rudan, Tristan Millington, Karen Antal, Zoe Grange, Lynda Fenton, Christopher Sullivan, et al. (+18)
58 [GO] 2022―Sep―23 Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) Giulia Vivaldi, David A. Jolliffe, Hayley Holt, Florence Tydeman, Mohammad Talaei, Gwyneth A. Davies, et al. (+6)
59 [GO] 2022―Sep―16 SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis Massimiliano Di Filippo, Lorenzo Gaetani
60 [GO] 2022―Sep―13 SARS-CoV-2 vaccination in haemodialysis patients: Insides from a prospective study comparing mRNA and viral vector vaccines Louise Füessl, Ulf Schönermarck
61 [GO] 2022―Sep―10 Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study Paul Martin, Sarah Gleeson, Candice L. Clarke, Tina Thomson, Helena Edwards, Katrina Spensley, et al. (+10)
62 [GO] 2022―Sep―07 Migrant-inclusive healthcare delivery in the UK: Lessons learned from the COVID-19 Pandemic Rachel Burns, Kerrie Stevenson, Anna Miller, Sally Hargreaves
63 [GO] 2022―Sep―02 SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, et al. (+9)
64 [GO] 2022―Sep―01 Post-infection rehabilitation of COVID-19 patients: Findings and prospects Hui Zhang, Bin Cao
65 [GO] 2022―Aug―25 Physical recovery across care pathways up to 12 months after hospitalization for COVID-19: A multicenter prospective cohort study (CO-FLOW) Julia C. Berentschot, Majanka H. Heijenbrok-Kal, L. Martine Bek, Susanne M. Huijts, Jasper van Bommel, Michel E. van Genderen, et al. (+31)
66 [GO] 2022―Aug―24 Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020-2021 James R. Hargreaves, Sinéad M. Langan, William E. Oswald, Katherine E. Halliday, Joanna Sturgess, Jody Phelan, et al. (+67)
67 [GO] 2022―Aug―23 Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: A prospective multicentric surveillance study in France Pr Robert Cohen, Alexis Rybak, Andreas Werner, Stéphane Béchet, Roxane Desandes, Fréderic Hassid, et al. (+10)
68 [GO] 2022―Aug―18 Science and beyond science in the reporting of quality of facility-based maternal and newborn care during the COVID-19 pandemic-Authors’ reply Marzia Lazzerini, Raquel Costa, Ilaria Mariani, Eline Skirnisdottir Vik, Helen Elden, Karolina Linden, et al. (+7)
69 [GO] 2022―Aug―10 Correction to “Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study”
70 [GO] 2022―Aug―10 Science and beyond science in the reporting of quality of facility-based maternal and newborn care during the COVID-19 pandemic J. Bernardes, A. Reynolds
71 [GO] 2022―Aug―08 Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study Catherine Hyams, Robert Challen, Elizabeth Begier, Jo Southern, Jade King, Anna Morley, et al. (+66)
72 [GO] 2022―Aug―05 Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study Christian Erikstrup, Anna Damkjær Laksafoss, Josephine Gladov, Kathrine Agergård Kaspersen, Susan Mikkelsen, Lotte Hindhede, et al. (+21)
73 [GO] 2022―Aug―04 Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response Evelina Tacconelli, Anna Gorska, Elena Carrara, Ruth Joanna Davis, Marc Bonten, Alex W. Friedrich, et al. (+12)
74 [GO] 2022―Jul―28 Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys Marc Chadeau-Hyam, David Tang, Oliver Eales, Barbara Bodinier, Haowei Wang, Jakob Jonnerby, et al. (+15)
75 [GO] 2022―Jul―22 Corrections to “Quality of facility-based maternal and newborn care around the time of childbirth during the COVID-19 pandemic: Online survey investigating maternal perspectives in 12 countries of the WHO European Region”
76 [GO] 2022―Jul―13 Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden Peter Nordström, Marcel Ballin, Anna Nordström
77 [GO] 2022―Jul―08 Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study Erika Molteni, Liane S. Canas, Kerstin Kläser, Jie Deng, Sunil S. Bhopal, Robert C. Hughes, et al. (+16)
78 [GO] 2022―Jul―01 Lessons from COVID-19 are shaping the response to monkeypox outbreak The Lancet Regional Health - Europe
79 [GO] 2022―Jul―01 Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission Mattia Manica, Alfredo De Bellis, Giorgio Guzzetta, Pamela Mancuso, Massimo Vicentini, Francesco Venturelli, et al. (+16)
80 [GO] 2022―Jul―01 Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study Snežana Medić, Cleo Anastassopoulou, Zagorka Lozanov-Crvenković, Vladimir Vuković, Nataša Dragnić, Vladimir Petrović, et al. (+5)
81 [GO] 2022―Jun―30 Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France Laura Semenzato, Jérémie Botton, Jérôme Drouin, Bérangère Baricault, Marion Bertrand, Marie-Joëlle Jabagi, et al. (+5)
82 [GO] 2022―Jun―30 Migrants’ primary care utilisation before and during the COVID-19 pandemic in England: An interrupted time series analysis Claire X. Zhang, Yamina Boukari, Neha Pathak, Rohini Mathur, Srinivasa Vittal Katikireddi, Parth Patel, et al. (+8)
83 [GO] 2022―Jun―30 Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data Daniela Michlmayr, Christian Holm Hansen, Sophie Madeleine Gubbels, Palle Valentiner-Branth, Peter Bager, Niels Obel, et al. (+6)
84 [GO] 2022―Jun―30 Adverse SARS-CoV-2-associated outcomes among people experiencing social marginalisation and psychiatric vulnerability: A population-based cohort study among 4,4 million people Sandra Feodor Nilsson, Thomas Munk Laursen, Merete Osler, Carsten Hjorthøj, Michael E. Benros, Steen Ethelberg, et al. (+2)
85 [GO] 2022―Jun―28 Comparison of trends in Clostridioides difficile infections in hospitalised patients during the first and second waves of the COVID-19 pandemic: A retrospective sentinel surveillance study Karuna E.W. Vendrik, Amoe Baktash, Jelle J. Goeman, Céline Harmanus, Daan W. Notermans, Sabine C. de Greeff, Ed J. Kuijper
86 [GO] 2022―Jun―16 Impact of COVID-19 pandemic on asthma exacerbations: Retrospective cohort study of over 500,000 patients in a national English primary care database Syed Ahmar Shah, Jennifer K. Quint, Aziz Sheikh
87 [GO] 2022―May―29 Willingness to receive an annual COVID-19 booster vaccine in the German-speaking D-A-CH region in Europe: A cross-sectional study Jakob Weitzer, Brenda M. Birmann, Ilja Steffelbauer, Martin Bertau, Lukas Zenk, Guido Caniglia, et al. (+3)
88 [GO] 2022―May―29 COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study Guillaume Favre, Emeline Maisonneuve, Léo Pomar, Ursula Winterfeld, Charlotte Daire, Begoña Martinez de Tejada, et al. (+16)
89 [GO] 2022―May―29 Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study Iván D. Benítez, Jordi de Batlle, Gerard Torres, Jessica González, David de Gonzalo-Calvo, Adriano D.S. Targa, et al. (+65)
90 [GO] 2022―May―29 Balancing risk and benefit of SARS-CoV-2 vaccines in children Michael Levin, Elizabeth Whittaker
91 [GO] 2022―May―11 Temporal changes of the incidence of childhood cancer in Germany during the COVID-19 pandemic: Updated analyses from the German Childhood Cancer Registry Friederike Erdmann, Claudia Spix, Martin Schrappe, Arndt Borkhardt, Joachim Schüz
92 [GO] 2022―May―02 Autopsies in COVID-related deaths: The need for following the model of German COVID-19 autopsy registry Cristoforo Pomara, Monica Salerno, Alessandro Miani, Prisco Piscitelli
93 [GO] 2022―Apr―29 Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study Naïm Ouldali, Haleh Bagheri, Francesco Salvo, Denise Antona, Antoine Pariente, Claire Leblanc, et al. (+16)
94 [GO] 2022―Apr―29 Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia Anneli Uusküla, Tuuli Jürgenson, Heti Pisarev, Raivo Kolde, Tatjana Meister, Anna Tisler, et al. (+4)
95 [GO] 2022―Apr―27 Self-perception of acute symptoms in adolescents with COVID-19 Massimiliano Gnecchi
96 [GO] 2022―Apr―22 Coronavirus vaccine hesitancy among unvaccinated Austrians: Assessing underlying motivations and the effectiveness of interventions based on a cross-sectional survey with two embedded conjoint experiments Tanja A. Stamm, Julia Partheymüller, Erika Mosor, Valentin Ritschl, Sylvia Kritzinger, Jakob-Moritz Eberl
97 [GO] 2022―Apr―22 Workplace contact patterns in England during the COVID-19 pandemic: Analysis of the Virus Watch prospective cohort study Sarah Beale, Susan Hoskins, Thomas Byrne, Wing Lam Erica Fong, Ellen Fragaszy, Cyril Geismar, et al. (+9)
98 [GO] 2022―Apr―21 Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, Julien Labreuche, Anne Goffard, Jacques Trauet, et al. (+19)
99 [GO] 2022―Apr―14 Cerebral venous thrombosis after COVID-19 vaccines: Do we know the mechanism? Cesare de Gregorio, Giuseppe Calcaterra, Nicholas G. Kounis, Pier Paolo Bassareo, Jawahar L. Mehta
100 [GO] 2022―Apr―12 Persistent symptoms after the first wave of COVID-19 in relation to SARS-CoV-2 serology and experience of acute symptoms: A nested survey in a population-based cohort Olivier Robineau, Emmanuel Wiernik, Cédric Lemogne, Xavier de Lamballerie, Laetitia Ninove, Hélène Blanché, et al. (+8)
101 [GO] 2022―Apr―11 Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis Yang Liu, Carl A.B. Pearson, Frank G. Sandmann, Rosanna C. Barnard, Jong-Hoon Kim, Stefan Flasche, et al. (+2)
102 [GO] 2022―Apr―11 The epidemiological relevance of the COVID-19-vaccinated population is decreasing after booster vaccination, as shown by incidence rate ratios Jürgen A. Bohnert, Lena Ulm, Nils-Olaf Hübner, Ulrike Seifert, Karsten Becker, Axel Kramer
103 [GO] 2022―Apr―11 Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study Julian Stumpf, Jörg Schwöbel, Tom Lindner, Leona Anders, Torsten Siepmann, Claudia Karger, et al. (+31)
104 [GO] 2022―Apr―04 The epidemiological relevance of the COVID-19-vaccinated population is decreasing after booster vaccination, as shown by incidence rate ratios-author's reply Günter Kampf
105 [GO] 2022―Mar―30 Persistent symptoms after SARS-CoV-2 infection: Long-term implications for health and quality of life Mike K.P. So, Amanda M.Y. Chu, Agnes Tiwari
106 [GO] 2022―Mar―25 Vaccination against SARS-CoV-2 infection among vulnerable and marginalised population groups in Denmark: A nationwide population-based study Sandra Feodor Nilsson, Thomas Munk Laursen, Merete Osler, Carsten Hjorthøj, Michael E. Benros, Steen Ethelberg, et al. (+2)
107 [GO] 2022―Mar―25 Acute symptoms in SARS-CoV-2 positive adolescents aged 15-18 years - Results from a Danish national cross-sectional survey study Selina Kikkenborg Berg, Pernille Palm, Susanne Dam Nielsen, Ulrikka Nygaard, Henning Bundgaard, Camilla Rotvig, Anne Vinggaard Christensen
108 [GO] 2022―Mar―22 Outdoor mass gathering events and SARS-CoV-2 infection in Catalonia (North-East Spain) Oren Miron, Kun-Hsing Yu
109 [GO] 2022―Mar―15 Abortion in Northern Ireland: Decriminalisation, COVID-19 and recent data Richard Armitage
110 [GO] 2022―Feb―28 Association between two mass-gathering outdoor events and incidence of SARS-CoV-2 infections during the fifth wave of COVID-19 in north-east Spain: A population-based control-matched analysis Clara Suñer, Ermengol Coma, Dan Ouchi, Eduardo Hermosilla, Bàrbara Baro, Miquel Àngel Rodríguez-Arias, et al. (+4)
111 [GO] 2022―Feb―26 The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden Malin Spetz, Lisa Lundberg, Chioma Nwaru, Huiqi Li, Ailiana Santosa, Susannah Leach, et al. (+4)
112 [GO] 2022―Feb―18 First report from the German COVID-19 autopsy registry Saskia von Stillfried, Roman David Bülow, Rainer Röhrig, Peter Boor, Jana Böcker, Jens Schmidt, et al. (+133)
113 [GO] 2022―Feb―17 Social vulnerability indices: A pragmatic tool for COVID-19 policy and beyond Jasmine C. Mah, Melissa K. Andrew
114 [GO] 2022―Feb―13 Time varying association between deprivation, ethnicity and SARS-CoV-2 infections in England: A population-based ecological study Tullia Padellini, Radka Jersakova, Peter J. Diggle, Chris Holmes, Ruairidh E. King, Brieuc C.L. Lehmann, et al. (+4)
115 [GO] 2022―Feb―03 Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK Elise Paul, Daisy Fancourt
116 [GO] 2022―Feb―01 COVID-19 outbreaks in acute and long-term care: Conceptualizing patterns of vulnerability and benefits of interventions Melissa K. Andrew, Shelly A. McNeil
117 [GO] 2022―Feb―01 The EU's global action in support of universal health coverage in the time of the pandemic and beyond Christian Franz, Laslo Jaeger, Urška Erklavec, Göran Tomson, Ilona Kickbusch, Vesna Kerstin Petrič, Pia Vračko
118 [GO] 2022―Jan―26 Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women - time for policies to change Hilde Engjom, Thomas van den Akker, Anna Aabakke, Outi Ayras, Kitty Bloemenkamp, Serena Donati, et al. (+3)
119 [GO] 2022―Jan―14 SARS-CoV-2 outbreaks in hospitals and long-term care facilities in Germany: a national observational study Beneditta Suwono, Annika Steffen, Birgitta Schweickert, Viktoria Schönfeld, Michael Brandl, Mirco Sandfort, et al. (+3)
120 [GO] 2022―Jan―10 Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65 Anna Schultze, Emily Nightingale, David Evans, William Hulme, Alicia Rosello, Chris Bates, et al. (+36)
121 [GO] 2022―Jan―10 Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study Chad R. Wells, Abhishek Pandey, Meagan C. Fitzpatrick, William S. Crystal, Burton H. Singer, Seyed M. Moghadas, et al. (+2)
122 [GO] 2022―Jan―10 Withdrawal notice to: COVID-19 situation in Germany should not be based on analyzing pre-pandemic patterns of contacts> <[The Lancet Regional Health Europe 12 (2022) 100290]> Günter Kampf
123 [GO] 2022―Jan―04 Persistent hesitancy for SARS-CoV-2 vaccines among healthcare workers in the United Kingdom: analysis of longitudinal data from the UK-REACH cohort study Christopher A. Martin, Katherine Woolf, Luke Bryant, Sue Carr, Laura J. Gray, Amit Gupta, et al. (+10)
124 [GO] 2022―Jan―02 The benefits, costs and feasibility of a low incidence COVID-19 strategy Thomas Czypionka, Emil N. Iftekhar, Barbara Prainsack, Viola Priesemann, Simon Bauer, André Calero Valdez, et al. (+17)
125 [GO] 2021―Dec―30 Static Socio-Ecological COVID-19 Vulnerability Index and Vaccine Hesitancy Index for England Claire E. Welsh, David R. Sinclair, Fiona E. Matthews
126 [GO] 2021―Dec―24 Quality of facility-based maternal and newborn care around the time of childbirth during the COVID-19 pandemic: online survey investigating maternal perspectives in 12 countries of the WHO European Region Marzia Lazzerini, Benedetta Covi, Ilaria Mariani, Zalka Drglin, Maryse Arendt, Ingvild Hersoug Nedberg, et al. (+27)
127 [GO] 2021―Dec―23 Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study Andrea Lombardi, Giacomo M. Butta, Lorena Donnici, Giorgio Bozzi, Massimo Oggioni, Patrizia Bono, et al. (+16)
128 [GO] 2021―Dec―14 Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study Liza Coyer, Anders Boyd, Janke Schinkel, Charles Agyemang, Henrike Galenkamp, Anitra D.M. Koopman, et al. (+10)
129 [GO] 2021―Dec―13 Analyzing pre-pandemic patterns of contacts is partly inappropriate to explain the current COVID-19 situation in Germany Günter Kampf
130 [GO] 2021―Dec―13 Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England Nick J Andrews, Julia Stowe, Mary EB Ramsay, Elizabeth Miller
131 [GO] 2021―Dec―12 Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance Emma Pritchard, Joel Jones, Karina-Doris Vihta, Nicole Stoesser, Prof Philippa C. Matthews, David W. Eyre, et al. (+13)
132 [GO] 2021―Dec―06 Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. Thomas Thiele, Karin Weisser, Linda Schönborn, Markus B. Funk, Gabriele Weber, Andreas Greinacher, Brigitte Keller-Stanislawski
133 [GO] 2021―Dec―01 Rethinking COVID-19 vaccine allocation: it is time to care about our neighbours Sebastian Contreras, Álvaro Olivera-Nappa, Viola Priesemann
134 [GO] 2021―Nov―30 Population level physical activity before and during the first national COVID-19 lockdown: A nationally representative repeat cross-sectional study of 5 years of Active Lives data in England Tessa Strain, Stephen J. Sharp, Andrew Spiers, Helen Price, Ciara Williams, Carol Fraser, et al. (+3)
135 [GO] 2021―Nov―30 Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study Yang Liu, Frank G. Sandmann, Rosanna C. Barnard, Carl A.B. Pearson, Roberta Pastore, Richard Pebody, et al. (+2)
136 [GO] 2021―Nov―29 Nocebo affects after COVID-19 vaccination Professor Peter Sever
137 [GO] 2021―Nov―29 Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) Michael Makris, Sue Pavord
138 [GO] 2021―Nov―26 Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France Rebecca Grant, Tiffany Charmet, Laura Schaeffer, Simon Galmiche, Yoann Madec, Cassandre Von Platen, et al. (+11)
139 [GO] 2021―Nov―20 The epidemiological relevance of the COVID-19-vaccinated population is increasing Günter Kampf
140 [GO] 2021―Nov―04 Surveillance of endemic human Coronaviruses in Germany, 2019/2020 Barbara Biere, Djin-Ye Oh, Thorsten Wolff, Ralf Dürrwald
141 [GO] 2021―Nov―04 The impact of COVID-19 in nursing homes in Madrid, Spain: a need for assessment Gergana Koleva, Manuel Rico, Fernando J. García López, Diego Figuera, Javier Padilla, Mónica García
142 [GO] 2021―Nov―04 Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study Raquel Carbonell, Silvia Urgelés, Alejandro Rodríguez, María Bodí, Ignacio Martín-Loeches, Jordi Solé-Violán, et al. (+22)
143 [GO] 2021―Nov―04 Call to apply a consistent scale in public COVID-19 reporting Günter Kampf
144 [GO] 2021―Nov―04 Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study Rana Shibli, Ofra Barnett, Zomoroda Abu-Full, Naomi Gronich, Ronza Najjar-Debbiny, Ilana Doweck, et al. (+2)
145 [GO] 2021―Nov―03 An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, et al. (+26)
146 [GO] 2021―Oct―28 Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study Hester Allen, Amoolya Vusirikala, Joe Flannagan, Katherine A. Twohig, Asad Zaidi, Dimple Chudasama, et al. (+9)
147 [GO] 2021―Oct―28 Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review Martina Amanzio, Dimos D Mitsikostas, Fabio Giovannelli, Massimo Bartoli, Giuseppina Elena Cipriani, Walter A Brown
148 [GO] 2021―Oct―26 Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients-Authors´ Reply Julian Stumpf, Christian Hugo
149 [GO] 2021―Oct―25 Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients Sandra Hasmann, Michael Paal, Louise Füeßl, Michael Fischereder, Ulf Schönermarck
150 [GO] 2021―Oct―19 Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study Peter Nordström, Marcel Ballin, Anna Nordström
151 [GO] 2021―Oct―12 All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study Jayati Das-Munshi, Chin Kuo Chang, Ioannis Bakolis, Matthew Broadbent, Alex Dregan, Matthew Hotopf, et al. (+2)
152 [GO] 2021―Oct―12 Ethical insights from the COVID-19 pandemic in Germany: considerations for building resilient healthcare systems in Europe Amelia Fiske, Stuart McLennan, Alena Buyx
153 [GO] 2021―Oct―12 Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic Mark Jit, Aparna Ananthakrishnan, Martin McKee, Olivier J. Wouters, Philippe Beutels, Yot Teerawattananon
154 [GO] 2021―Oct―12 Building health system resilience through policy development in response to COVID-19 in Ireland: From shock to reform Sara Burke, Sarah Parker, Padraic Fleming, Sarah Barry, Steve Thomas
155 [GO] 2021―Oct―12 Shaping EU medicines regulation in the post COVID-19 era Marco Cavaleri, Fergus Sweeney, Rosa Gonzalez-Quevedo, Melanie Carr
156 [GO] 2021―Oct―12 Pandemics- One Health preparedness for the next Frank M. Aarestrup, Marc Bonten, Marion Koopmans
157 [GO] 2021―Sep―11 Why we may need to rethink future SARS-CoV-2 vaccination strategies Peter Klimek
158 [GO] 2021―Sep―03 Pandemic heightens the need to combat cardiovascular diseases
159 [GO] 2021―Aug―18 Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: Evidence from the German Childhood Cancer Registry and a qualitative survey Friederike Erdmann, Maike Wellbrock, Claudia Trübenbach, Claudia Spix, Martin Schrappe, Joachim Schüz, et al. (+2)
160 [GO] 2021―Aug―18 Restricted access to the NHS during the COVID-19 pandemic: Is it time to move away from the rationed clinical response? Daniel K Goyal, Fatma Mansab, Adeeb P Naasan, Amir Iqbal, Colin Millar, Grant Franklin, et al. (+4)
161 [GO] 2021―Aug―18 COVID-19′s impact on home health services, caregivers and patients: lessons from the French experience Eva Brocard, Pierre Antoine, Pascal Mélihan-Cheinin, Emmanuel Rusch
162 [GO] 2021―Aug―18 SARS-CoV-2 vaccination for immune-comprised patients: More is required Hui Li, Jiapei Yu, Bin Cao
163 [GO] 2021―Aug―17 Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing Géraldine Rios, Caroline Lacoux, Vianney Leclercq, Anna Diamant, Kévin Lebrigand, Adèle Lazuka, et al. (+9)
164 [GO] 2021―Aug―06 Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol Louise Sigfrid, Thomas M Drake, Ellen Pauley, Edwin C Jesudason, Piero Olliaro, Wei Shen Lim, et al. (+29)
165 [GO] 2021―Aug―01 Beware of regional heterogeneity when assessing the role of schools in the SARS-CoV-2 second wave in Italy-Authors´ reply. Sara Gandini, Maurizio Rainisio, Maria Luisa Iannuzzo, Federica Bellerba, Francesco Cecconi, Luca Scorrano
166 [GO] 2021―Jul―30 A look into the future of the COVID-19 pandemic in Europe: an expert consultation Emil Nafis Iftekhar, Viola Priesemann, Rudi Balling, Simon Bauer, Philippe Beutels, André Calero Valdez, et al. (+28)
167 [GO] 2021―Jul―23 Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine Julian Stumpf, Torsten Siepmann, Tom Lindner, Claudia Karger, Jörg Schwöbel, Leona Anders, et al. (+38)
168 [GO] 2021―Jul―19 Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study Katherine Woolf, I Chris McManus, Christopher A Martin, Laura B Nellums, Anna L Guyatt, Carl Melbourne, et al. (+17)
169 [GO] 2021―Jul―17 Beware of regional heterogeneity when assessing the role of schools in the SARS-CoV-2 second wave in Italy Simona Bignami-Van Assche, Yacine Boujija, Daniela Ghio, Nikolaos I. Stilianakis
170 [GO] 2021―Jul―16 Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people Laura Semenzato, Jérémie Botton, Jérôme Drouin, François Cuenot, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik
171 [GO] 2021―Jul―15 Covid-19: Regional policies and local infection risk: Evidence from Italy with a modelling study Gabriele Guaitoli, Roberto Pancrazi
172 [GO] 2021―Jul―14 Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany Bjoern Jensen, Nadine Luebke, Torsten Feldt, Verena Keitel, Timo Brandenburger, Detlef Kindgen-Milles, et al. (+9)
173 [GO] 2021―Jul―14 Social network-based cohorting to reduce the spread of SARS-CoV-2 in secondary schools: A simulation study in classrooms of four European countries Anna Karoline Kaiser, David Kretschmer, Lars Leszczensky
174 [GO] 2021―Jul―13 Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France Tiffany Charmet, Laura Schaeffer, Rebecca Grant, Simon Galmiche, Olivia Chény, Cassandre Von Platen, et al. (+15)
175 [GO] 2021―Jul―01 The impact of COVID-19 on primary care in Europe Dr F Mughal, CD Mallen, M McKee
176 [GO] 2021―Jun―27 Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases Olaf Müller, Oliver Razum, Albrecht Jahn
177 [GO] 2021―Jun―27 Different spreading dynamics throughout Germany during the second wave of the COVID-19 pandemic: a time series study based on national surveillance data Andreas Schuppert, Katja Polotzek, Jochen Schmitt, Reinhard Busse, Jens Karschau, Christian Karagiannidis
178 [GO] 2021―Jun―19 Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020 Alexander Ullrich, Madlen Schranz, Ute Rexroth, Osamah Hamouda, Lars Schaade, Michaela Diercke, T. Sonia Boender
179 [GO] 2021―Jun―08 Excess deaths from COVID-19 and other causes by region, neighbourhood deprivation level and place of death during the first 30 weeks of the pandemic in England and Wales: A retrospective registry study Evangelos Kontopantelis, Mamas A. Mamas, Roger T. Webb, Ana Castro, Martin K. Rutter, Chris P. Gale, et al. (+10)
180 [GO] 2021―Jun―07 Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data Djin-Ye Oh, Silke Buda, Barbara Biere, Janine Reiche, Frank Schlosser, Susanne Duwe, et al. (+5)
181 [GO] 2021―Jun―07 Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study Simon Galmiche, Tiffany Charmet, Laura Schaeffer, Juliette Paireau, Rebecca Grant, Olivia Chény, et al. (+13)
182 [GO] 2021―Jun―07 Addressing poverty post COVID-19 pandemic
183 [GO] 2021―Jun―05 A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020-February 2021 Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, et al. (+3)
184 [GO] 2021―Jun―05 Challenges in the equitable access to COVID-19 vaccines for migrant populations in Europe Benedetta Armocida, Beatrice Formenti, Eduardo Missoni, Clelia D'Apice, Valentina Marchese, Marzia Calvi, et al. (+2)
185 [GO] 2021―May―27 Are low SARS-CoV-2 viral loads in infected children missed by RT-PCR testing?
186 [GO] 2021―May―26 The pandemic in French intensive care units-Author's response Djillali Annane
187 [GO] 2021―May―25 The pandemic in French intensive care units Marc Leone, Laurent Delaunay, Hervé Bouaziz
188 [GO] 2021―May―21 Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra Cristina Royo-Cebrecos, David Vilanova, Joel López, Vanesa Arroyo, Marc Pons, Guillem Francisco, et al. (+5)
189 [GO] 2021―May―19 The complex picture of self-harm during the COVID-19 pandemic Ruoling Chen
190 [GO] 2021―May―19 COVID-19 outbreaks following full reopening of primary and secondary schools in England: Cross-sectional national surveillance, November 2020 Felicity Aiano, Anna A Mensah, Kelsey McOwat, Chinelo Obi, Amoolya Vusirikala, Annabel A Powell, et al. (+11)
191 [GO] 2021―May―18 Prevalence and changes in food-related hardships by socioeconomic and demographic groups during the COVID-19 pandemic in the UK: A longitudinal panel study Jonathan Koltai, Veronica Toffolutti, Martin McKee, David Stuckler
192 [GO] 2021―May―18 Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study Max Augustin, Philipp Schommers, Melanie Stecher, Felix Dewald, Lutz Gieselmann, Henning Gruell, et al. (+20)
193 [GO] 2021―May―18 SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study Katherine M Gaskell, Marina Johnson, Victoria Gould, Adam Hunt, Neil RH Stone, William Waites, et al. (+7)
194 [GO] 2021―May―17 Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? Claude P. Muller
195 [GO] 2021―May―12 Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of Liverpool, UK (November 2020 to January 2021) Mark A. Green, Marta García-Fiñana, Ben Barr, Girvan Burnside, Christopher P. Cheyne, David Hughes, et al. (+3)
196 [GO] 2021―May―08 Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform Krishnan Bhaskaran, Sebastian Bacon, Stephen JW Evans, Chris J Bates, Christopher T Rentsch, Brian MacKenna, et al. (+21)
197 [GO] 2021―May―06 Waning antibodies to SARS-CoV-2 - Don't panic Benjamin Meyer
198 [GO] 2021―May―02 Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults Helen Ward, Graham S. Cooke, Christina Atchison, Matthew Whitaker, Joshua Elliott, Maya Moshe, et al. (+10)
199 [GO] 2021―Apr―30 Hospitalization for self-harm during the early months of the COVID-19 pandemic in France: A nationwide retrospective observational cohort study Fabrice JOLLANT, Adrien ROUSSOT, Emmanuelle CORRUBLE, Jean-Christophe CHAUVET-GELINIER, Bruno FALISSARD, Yann MIKAELOFF, Catherine QUANTIN
200 [GO] 2021―Apr―30 Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study Aidin Rawshani, Elin Allansson Kjölhede, Araz Rawshani, Naveed Sattar, Katarina Eeg-Olofsson, Martin Adiels, et al. (+7)
201 [GO] 2021―Apr―30 Changes in COVID-19 in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: An observational study using administrative data William K. Gray, Annakan V Navaratnam, Jamie Day, Julia Wendon, Tim W.R. Briggs
202 [GO] 2021―Apr―25 Generalisation of COVID-19 incidences provides a biased view of the actual epidemiological situation Paul Wilmes, Joël Mossong, Thomas G. Dentzer
203 [GO] 2021―Apr―20 Suicide in England in the COVID-19 pandemic: Early observational data from real time surveillance Louis Appleby, Nicola Richards, Saied Ibrahim, Pauline Turnbull, Cathryn Rodway, Nav Kapur
204 [GO] 2021―Apr―19 Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study Sergey Yegorov, Maiya Goremykina, Raifa Ivanova, Sara V. Good, Dmitriy Babenko, Alexandr Shevtsov, et al. (+2)
205 [GO] 2021―Apr―16 Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study Kathleen E. Bennett, Maeve Mullooly, Mark O'Loughlin, Margaret Fitzgerald, Joan O'Donnell, Lois O'Connor, et al. (+2)
206 [GO] 2021―Apr―15 Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak Przemyslaw Kardas, Job Frank Martien van Boven, Hilary Pinnock, Enrica Menditto, Björn Wettermark, Ioanna Tsiligianni, Tamás Ágh
207 [GO] 2021―Apr―15 The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry Urška Ivanuš, Tine Jerman, Urška Gašper Oblak, Leon Meglič, Mojca Florjančič, Margareta Strojan Fležar, et al. (+9)
208 [GO] 2021―Apr―14 Getting hands on a drug for Covid-19: Inhaled and Intranasal Niclosamide Karl Kunzelmann
209 [GO] 2021―Apr―06 A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19 Vibeke Backer, Ulf Sjöbring, Jesper Sonne, Anne Weiss, Morten Hostrup, Helle Krogh Johansen, et al. (+5)
210 [GO] 2021―Mar―31 Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study Kanika Kuwelker, Fan Zhou, Bjørn Blomberg, Sarah Lartey, Karl Albert Brokstad, Mai Chi Trieu, et al. (+20)
211 [GO] 2021―Mar―28 Adolescents’ symptoms of anxiety and depression before and during the Covid-19 outbreak - A prospective population-based study of teenagers in Norway Gertrud Sofie Hafstad, Sjur Skjørshammer Sætren, Tore Wentzel-Larsen, Else-Marie Augusti
212 [GO] 2021―Mar―26 A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy Sara Gandini, Maurizio Rainisio, Maria Luisa Iannuzzo, Federica Bellerba, Francesco Cecconi, Luca Scorrano
213 [GO] 2021―Mar―23 Reply to “Focusing COVID-19 vaccinations on elderly and high-risk people” Olaf Müller, Guangyu Lu, Oliver Razum, Albrecht Jahn
214 [GO] 2021―Mar―23 Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020 Jessica Flood, Joseph Shingleton, Emma Bennett, Brodie Walker, Zahin Amin-Chowdhury, Godwin Oligbu, et al. (+17)
215 [GO] 2021―Mar―23 Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the United Kingdom and Ireland: What is new? Pier Paolo Bassareo
216 [GO] 2021―Mar―23 Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 prospective cohort study Peter Willeit, Robert Krause, Bernd Lamprecht, Andrea Berghold, Buck Hanson, Evelyn Stelzl, et al. (+12)
217 [GO] 2021―Mar―21 Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium - Authors' reply Fabio Silvio TACCONE, Nina VAN GOETHEM, Robby DE PAUW, Dominique VAN BECKHOVEN, Geert MEYFROIDT, Koen BLOT
218 [GO] 2021―Mar―21 Do asymptomatic carriers of SARS-COV-2 transmit the virus? Claude P. Muller
219 [GO] 2021―Mar―21 Prisons need to be included in global and national vaccinations effort against COVID-19 Maria Neufeld, Filipa Alves da Costa, Carina Ferreira-Borges
220 [GO] 2021―Mar―21 Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium Jigar Patel, Rajesh Naidu Janapala, Omar Belfaqeeh, Abdulla Alhashmi, Ali Pourmand
221 [GO] 2021―Mar―21 Maximising public adherence to COVID-19 self-isolation in Europe Jay Patel, Genevie Fernandes, Devi Sridhar
222 [GO] 2021―Mar―21 Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis Noémie Lefrancq, Juliette Paireau, Nathanaël Hozé, Noémie Courtejoie, Yazdan Yazdanpanah, Lila Bouadma, et al. (+4)
223 [GO] 2021―Mar―20 The management of COVID-19 in Madrid Ángel López-Encuentra, Pablo Lázaro y de Mercado, Víctor Abraira, Sergio García Rull, Francisco Pozo Rodríguez
224 [GO] 2021―Mar―20 Integral management of COVID-19 in Madrid: Turning things around during the second wave-Authorsá reply Francisco Javier Candel, Jesús San-Román, Pablo Barreiro, Jesús Canora, Antonio Zapatero, Mar Carretero, et al. (+2)
225 [GO] 2021―Mar―19 Reply to: Integral management of COVID-19 in Madrid: Turning things around during the second wave M Díaz-Menéndez, E Malmierca
226 [GO] 2021―Mar―19 Reply to “Integral management of COVID-19 in Madrid: Turning things around during the second wave” María-Victoria Zunzunegui, Fernando J.García López, Miguel Ángel Royo-Bordonada, Isabel Cienfuegos
227 [GO] 2021―Mar―19 Excess mortality for men and women above age 70 according to level of care during the first wave of COVID-19 pandemic in Sweden: A population-based study K. Modig, M. Lambe, A. Ahlbom, M. Ebeling
228 [GO] 2021―Mar―19 Pediatric admissions to emergency departments of North-Western Italy during COVID-19 pandemic: A retrospective observational study Irene Raffaldi, Emanuele Castagno, Ilaria Fumi, Claudia Bondone, Fulvio Ricceri, Luigi Besenzon, et al. (+22)
229 [GO] 2021―Mar―14 Reply to “Integral management of COVID-19 in Madrid: Turning things around during the second wave” Felix Lobo
230 [GO] 2021―Mar―14 Reply to "Integral management of COVID-19 in Madrid: Turning things around during the second wave" Mario Fontán-Vela, Pedro Gullón, Javier Padilla-Bernáldez
231 [GO] 2021―Mar―12 Is the worst of the pandemic over for Europe?
232 [GO] 2021―Mar―02 In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study Gianluca Campo, Daniela Fortuna, Elena Berti, Rossana De Palma, Giuseppe Di Pasquale, Marcello Galvani, et al. (+12)
233 [GO] 2021―Mar―02 Mass vaccination campaign for residents and workers and assistance to vulnerable populations during COVID-19 pandemic: The experience of the healthcare services of the Vatican City Massimo Ralli, Fabio De-Giorgio, Paolo Maurizio Soave, Lucia Ercoli, Andrea Arcangeli
234 [GO] 2021―Feb―27 Prevalence of mental disorders, suicidal ideation and suicides in the general population before and during the COVID-19 pandemic in Norway: A population-based repeated cross-sectional analysis Ann Kristin Skrindo Knudsen, Kim Stene-Larsen, Kristin Gustavson, Matthew Hotopf, Ronald C. Kessler, Steinar Krokstad, et al. (+3)
235 [GO] 2021―Feb―27 SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg Paul Wilmes, Jacques Zimmer, Jasmin Schulz, Frank Glod, Lisa Veiber, Laurent Mombaerts, et al. (+10)
236 [GO] 2021―Feb―26 Predictors of self-reported adherence to COVID-19 guidelines. A longitudinal observational study of 51,600 UK adults Liam Wright, Andrew Steptoe, Daisy Fancourt
237 [GO] 2021―Feb―26 Trend towards reduction in COVID-19 in-hospital mortality Annalisa Ruggeri, Giovanni Landoni, Fabio Ciceri
238 [GO] 2021―Feb―26 Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study Kristoffer Strålin, Erik Wahlström, Sten Walther, Anna M Bennet-Bark, Mona Heurgren, Thomas Lindén, et al. (+2)
239 [GO] 2021―Feb―26 The challenge of asymptomatic SARS-CoV-2 transmission in care homes Joël Belmin, Carmelo Lafuente-Lafuente
240 [GO] 2021―Feb―25 Evidencing the detrimental impact of the COVID-19 pandemic on mental health across Europe Roger T Webb, Sally McManus, Rory C O'Connor
241 [GO] 2021―Jan―29 Intensive care units, the Achilles heel of France in the COVID-19 battle Djillali Annane, Laura Federici, Jean-Luc Chagnon, Jean Luc Diehl, Didier Dreyfuss, Philippe Guiot, et al. (+10)
242 [GO] 2021―Jan―26 Focusing COVID-19 vaccinations on elderly and high-risk people Hermann Brenner
243 [GO] 2021―Jan―24 Trends in mortality of hospitalised COVID-19 patients: a single centre observational cohort study from Spain Carolina Garcia-Vidal, Alberto Cózar-Llistó, Fernanda Meira, Gerard Dueñas, Pedro Puerta-Alcalde, Catia Cilloniz, et al. (+16)
244 [GO] 2021―Jan―23 Integral management of COVID-19 in Madrid: Turning things around during the second wave. Francisco Javier Candel, Jesús San Román, Pablo Barreiro, Jesús Canora, Antonio Zapatero, Mar Carretero, et al. (+2)
245 [GO] 2021―Jan―22 Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: prospective observational cohort study, England 2020 Anna Jeffery-Smith, Kate Dun-Campbell, Roshni Janarthanan, Jonathan Fok, Emma Crawley-Boevey, Amoolya Vusirikala, et al. (+23)
246 [GO] 2021―Jan―20 Timely care for extrauterine pregnancies during the COVID-19 pandemic is needed Nina la Cour Freiesleben, Henriette Svarre Nielsen
247 [GO] 2021―Jan―14 Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: an observational study Eric Van Belle, Thibault Manigold, Adeline Piérache, Alain Furber, Nicolas Debry, Anne Luycx-Bore, et al. (+40)
248 [GO] 2021―Jan―14 Ceci n'est pas un lit*. Base capacity healthcare matters in a pandemic. Philippe Beutels, Frederik Verelst
249 [GO] 2021―Jan―14 COVID-19 vaccination in the UK: Addressing vaccine hesitancy Kalyani Sonawane, Catherine L. Troisi, Ashish A. Deshmukh
250 [GO] 2021―Jan―14 Effects of the COVID-19 pandemic on timely care for extrauterine pregnancies: A retrospective analysis Matan Anteby, Liel Van Mil, Nadav Michaan, Ido Laskov, Dan Grisaru
251 [GO] 2021―Jan―14 European Green Deal as Social Vaccine to Overcome COVID-19 Health & Economic Crisis Leonardo Becchetti, Prisco Piscitelli, Alessandro Distante, Alessandro Miani, Antonio Felice Uricchio
252 [GO] 2021―Jan―14 Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: a retrospective database study Steven Wyatt, Mohammed A Mohammed, Elizabeth Fisher, Ruth McConkey, Peter Spilsbury
253 [GO] 2021―Jan―10 Neutralising antibodies and virus isolation: the keys to control covert COVID-19 spread? Grégoire B. Morand
254 [GO] 2021―Jan―10 Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study Nazir I Lone, Joanne McPeake, Neil I Stewart, Michael C Blayney, Robert Chan Seem, Lorraine Donaldson, et al. (+8)
255 [GO] 2021―Jan―10 Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols Jordan P Skittrall, Mary D Fortune, Hamid Jalal, Hongyi Zhang, David A Enoch, Nicholas M Brown, Anne Swift
256 [GO] 2021―Jan―02 Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: a longitudinal analysis of 200,000 Western and Northern Europeans Tibor V. Varga, Feifei Bu, Agnete S. Dissing, Leonie K. Elsenburg, Joel J. Herranz Bustamante, Joane Matta, et al. (+11)
257 [GO] 2020―Dec―23 The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium Fabio Silvio TACCONE, Nina VANGOETHEM, Robby DEPAUW, Xavier WITTEBOLE, Koen BLOT, Herman VANOYEN, et al. (+4)
258 [GO] 2020―Dec―23 Maximising benefit, reducing inequalities and ensuring deliverability: prioritisation of COVID-19 vaccination in the UK Ines Campos-Matos, Sema Mandal, Julie Yates, Mary Ramsay, James Wilson, Wei Shen Lim
259 [GO] 2020―Dec―21 Cross Sectional investigation of a COVID-19 outbreak at a London Army barracks: neutralising antibodies and virus isolation Hannah Taylor, William Wall, David Ross, Roshni Janarthanan, Liyang Wang, Felicity Aiano, et al. (+10)
260 [GO] 2020―Dec―18 Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland Luca Piccoli, Paolo Ferrari, Giovanni Piumatti, Sandra Jovic, Blanca Fernandez Rodriguez, Federico Mele, et al. (+17)
261 [GO] 2020―Dec―18 Elimination of COVID-19 in the Faroe Islands: effectiveness of massive testing and intensive case and contact tracing. Marin Strøm, Marnar Fríðheim Kristiansen, Debes Hammershaimb Christiansen, Pál Weihe, Maria Skaalum Petersen
262 [GO] 2020―Dec―17 Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications Elise Paul, Andrew Steptoe, Daisy Fancourt
263 [GO] 2020―Dec―16 COVID-19 in Central Asia: Uzbekistan's new approach to international cooperation Alisher Shadmanov, Evgeniya Boklage, Oleg Storozhenko, Andreas Jansen
264 [GO] 2020―Dec―16 The inverse care law in critical care during the COVID-19 Pandemic Kirsten J Hainey, Srinivasa Vittal Katikireddi
 [1] 

264 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.028 sec